Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728318) titled 'Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Akhtar Saeed Medical and Dental College

Condition: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Intervention: Other: Tirzepatide + Standard Therapy (Intervention Group)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: August 12, 2026

Target Sample Size: 52

To know more, visit http...